2023 Form 5500 filing — Mahana Therapeutics, Inc. 401(K) Plan

Plain-English filing summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, this is the 2023 Form 5500 filing (EFAST2 acknowledgement 20250729171508NAL0005213056001) for Mahana Therapeutics, Inc. 401(K) Plan, reported by Mahana Therapeutics, Inc. under EIN 82-3995179 and plan number 001. It reports 87 participants. Attached schedules in the loaded dataset include Schedule I (small plan financials).

Form 5500 2 · 2023

Filing snapshot

Net assets (EOY)$2.8MReported net assets$2,750,189
Participants87
Provider compensationNone reported
Schedules filedSchedule ILoaded schedules
EFAST2 acknowledgement
20250729171508NAL0005213056001
Plan sponsor
Mahana Therapeutics, Inc.
EIN
82-3995179
Plan number
001
Location
Burlingame, CA
Received date
not reported in the loaded dataset
How to read this filing
  • This is a single annual Form 5500 filing, identified by its EFAST2 acknowledgement id.
  • Schedule chips (Sch H / I / C) show which schedules this filing includes.
  • Net assets = total assets minus total liabilities (Schedule H/I).
  • Fields a filing did not report are labeled not reported in the loaded dataset — never estimated.
  • For the plan's full history, open the plan profile.
Schedule I · 2023

Reported financial snapshot

Reported figures as filed, in whole dollars. Only fields the filing reports are shown.

Reported balance (end of year)$2.8M total assets
Net assets$2.8MLiabilities$0
Money in vs. money out
Total income / additions$982.7K
Total expenses$406K
Benefits paid / distributions$405.5K
Contributions
Employer$0
Participant$428.9K
Full reported line items
Total assets (EOY)
$2,750,189
Total liabilities (EOY)
$0
Net assets (EOY)
$2,750,189
Employer contributions
$0
Participant contributions
$428,950
Total income / additions
$982,722
Benefits paid
$405,536
Administrative expenses
$420
Total expenses
$405,956
Net increase / (decrease)
$576,766

What to inspect next

Frequently asked questions

What does EFAST2 acknowledgement 20250729171508NAL0005213056001 cover?
It is the 2023 Form 5500 filing for Mahana Therapeutics, Inc. 401(K) Plan, reported by Mahana Therapeutics, Inc. (EIN 82-3995179).
Which Form 5500 schedules are attached to this 2023 filing?
Attached schedules in the loaded dataset include Schedule I (small plan financials).

Related Form 5500 pages